Novavax Inc. buy jomobb
.jpg?locale=us "jomobb")
Start price
28.05.21
/
80%
€125.18
Target price
28.05.22
€200.00
Performance (%)
-35.69%
End price
29.01.22
€80.50
Summary
This prediction ended on 29.01.22 with a price of €80.50. The BUY prediction by jomobb for Novavax Inc. performed very badly with a performance of -35.69%. jomobb has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novavax Inc. | -6.235% | -6.235% | -14.123% | -34.190% |
| iShares Core DAX® | -3.141% | 1.269% | 16.367% | 60.124% |
| iShares Nasdaq 100 | -3.518% | -1.355% | 2.670% | 101.416% |
| iShares Nikkei 225® | -3.396% | 3.283% | 17.041% | 47.915% |
| iShares S&P 500 | -2.943% | -0.533% | 1.373% | 64.215% |
According to jomobb what are the pros and cons of Novavax Inc. for the foreseeable future?
Pros
Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Some uniques
Cons
Significant cyclical dependencies